Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Writeup, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 3.5 times, Oct-Dec Ordinary Profit Increases by 2.3 times
6580 Writeup Co.,Ltd. 【J-GAAP】
Earnings ReportWriteup Co.,Ltd. <6580> [TSE Growth] announced its financial results after the market closed on February 14th (15:50). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending March 2025 (April to December) surged 3.5 times that of the same period last year, reaching 276 million yen. The progress rate toward the full-year plan of 627 million yen was 44.0%, exceeding the five-year average of 39.3%.
Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the January to March period (4Q) is expected to expand 48.7% from the same period last year, reaching 351 million yen.
In the most recent three-month period, from October to December (3Q), the consolidated ordinary profit surged 2.3 times that of the same period last year, reaching 160 million yen. The operating profit margin rose from 10.7% in the same period last year to 13.4%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Apr - Dec, 2022 | 1,607 | 54 | 53 | 33 | 6.4 | 37.6 | Feb 14, 2023 | J-GAAP |
Apr - Dec, 2023 | 1,835 | 79 | 78 | 39 | 7.7 | 24.8 | Feb 14, 2024 | J-GAAP |
Apr - Dec, 2024 | 2,829 | 265 | 276 | 127 | 24.8 | 44.0 | Feb 14, 2025 | J-GAAP |
YoY | +54.2% | +235.4% | +253.8% | +225.6% | +223.5% |
Current Period Guidance
Second Half Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Mar, 2023 | 1,607 | 311 | 307 | 234 | 45.3 | 0 | May 15, 2024 | J-GAAP |
Oct - Mar, 2024 Guidance | 2,659 | 520 | 511 | 370 | 72.2 | 16.89 | Nov 14, 2024 | J-GAAP |
YoY | +65.5% | +67.2% | +66.4% | +58.1% | +59.5% |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2023 | 2,224 | 143 | 141 | 109 | 20.9 | 0 | May 15, 2023 | J-GAAP |
Mar, 2024 | 2,776 | 319 | 314 | 230 | 44.5 | 0 | May 15, 2024 | J-GAAP |
Mar, 2025 Guidance | 4,343 | 631 | 627 | 437 | 85.3 | 16.89 | Nov 14, 2024 | J-GAAP |
YoY | +56.4% | +97.8% | +99.7% | +90.0% | +91.6% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Dec, 2023 | 666 | 71 | 71 | 43 | 8.5 | 10.7 | Feb 14, 2024 | J-GAAP |
Jan - Mar, 2024 | 941 | 240 | 236 | 191 | 37.0 | 25.5 | May 15, 2024 | J-GAAP |
Apr - Jun, 2024 | 678 | -83 | -83 | -75 | -14.5 | -12.2 | Aug 9, 2024 | J-GAAP |
Jul - Sep, 2024 | 1,006 | 194 | 199 | 142 | 27.9 | 19.3 | Nov 14, 2024 | J-GAAP |
Oct - Dec, 2024 | 1,145 | 154 | 160 | 60 | 11.7 | 13.4 | Feb 14, 2025 | J-GAAP |
YoY | +71.9% | +116.9% | +125.4% | +39.5% | +38.6% |
Related Articles
cotta, Oct-Dec (1Q) Ordinary Profit Decreases by 14%
KIBUN FOODS, Oct-Dec (3Q) Ordinary Profit Decreases by 16%
HATSUHO SHOUJI, 4% Increase in Ordinary Profit for The Current Fiscal Year, Dividend Raised by 7 yen
MITSUBOSHI , Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 41%, Oct-Dec Ordinary Profit Increases by 38%
HIRAYAMA HOLDINGS, Oct-Dec (2Q) Ordinary Profit Decreases by 4%
TRADE WORKS, Returning to Profitability This Year
KIKUSUI CHEMICAL, Oct-Dec (3Q) Ordinary Profit Decreases by 46%
DENTSU, Net Income/Loss Unexpectedly Turn to Loss for Last Fiscal Year, Returning to Profitability This Year
AMUSE, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 2.6 times, Exceeds Full-Year Plan
RaQualia Pharma, Returning to Profitability This Year